Clinical Trial Update: Oral CDX-7108 in Healthy Adults and EPI Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of oral CDX-7108 in healthy adults and subjects with Exocrine Pancreatic Insufficiency has completed, sponsored by Société des Produits Nestlé (SP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency

Drugs mentioned

• CDX-7108

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Exocrine Pancreatic Insufficiency | Phase 1 | Status: COMPLETED